International: +1-347-960-6455

Research Reports

Filter By Therapeutic Area

Filtered by Report Category (Marketed API Reports)

Therapy Area
Tagraxofusp - API Insight, 2018
Therapeutic Area(s) Oncology

Tagraxofusp, sold under the brand name of Elzonris, is an Interleukin 3 (IL-3) conjugated truncated diphtheria toxin. It is composed of catalytic and translocation domains of diphtheria toxin fused via Met-His linker to a full-length human IL-3.

Therapy Area
Sufentanil - API Insight, 2018
Therapeutic Area(s) Neurology

Sufentanil, sold under the brand names of Dsuvia and Sufenta, is basically a synthetic opioid analgesic drug, which is used for the medication of acute pain relief. It helps to offer properties of sedation and this makes it a good analgesic component of anesthetic regimen during a surgical process.

Therapy Area
Cabozantinib- API Insight, 2018
Therapeutic Area(s) Oncology

Cabozantinib, sold under the brand name of Cabometyx and Cometriq, is used for the treatment of medullary thyroid cancer and a second line treatment for renal cell carcinoma. It is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2, and also inhibits AXL and RET.